LISSETTE LOPEZ: Open Payments
NPI 1003157041 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,963 in 129 payments from 16 companies in 2025. Trend: 2023 $1,910 · 2024 $4,678 · 2025 $2,963
Food & beverage: $2,878Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $709 |
| Janssen Biotech, Inc. | 27 | $525 |
| Incyte Corporation | 15 | $431 |
| Verrica Pharmaceuticals Inc. | 27 | $280 |
| Janssen Scientific Affairs, LLC | 2 | $208 |
| Amgen Inc. | 6 | $163 |
| Organon LLC | 7 | $118 |
| GENZYME CORPORATION | 7 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
Products named: TREMFYA, OPZELURA, RINVOQ, SKYRIZI, YCANTH, DUPIXENT, Otezla, COSENTYX.
Industry payments across CA — which companies pay providers there.
